Status:
RECRUITING
PET/MRI/EEG Imaging Study in Epilepsy
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Epilepsy
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to better understand how epilepsy alters brain function through neuroimaging of healthy people and people with epilepsy. The study investigates how changes in brain metabolism (sugar c...
Eligibility Criteria
Inclusion
- Age 18 or older
- Additional Inclusion Criteria for Subjects with Epilepsy:
- Diagnosed with epilepsy with abnormal interictal EEG
Exclusion
- Contraindications to PET, MRI, or EEG imaging
- History of severe brain disease such as stroke and head trauma
- History of brain surgery
- History of type I or II diabetes mellitus
- Fasting plasma glucose level \>200 mg/dL
- Employed under direct supervision of the PI conducting the research
- Additional Exclusion Criteria for Healthy Subjects:
- Current use of drugs that modulate brain function
- Current or past history of major medical, neurological, or psychiatric conditions
Key Trial Info
Start Date :
September 21 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06974305
Start Date
September 21 2023
End Date
November 30 2025
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Athinoula A. Martinos Center
Charlestown, Massachusetts, United States, 02129